PRESS: Celadon featured on ITV News
At Celadon Pharmaceuticals, innovation drives everything we do. We are proud to share an exciting development in our ongoing pursuit of excellence in healthcare solutions.
Yesterday evening, our groundbreaking chronic pain clinical trial was featured on ITV News. This was more than a media appearance; it was a testament to our unwavering commitment to improving patients’ lives through novel, cannabis-based medical solutions.
Addressing a Widespread Challenge
Chronic pain affects approximately 8 million people in the UK alone, ranging from moderate to severe disability. It’s a condition that diminishes the quality of life for many, and traditional treatments often fall short.
Our one-of-a-kind clinical trial, approved by UK regulators, is breaking new ground. The early data has shown very positive outcomes for pain reduction, enhanced sleep quality, and decreased reliance on opioids. We believe that our medicine can be a game-changer.
A Vision for the Future
Our ultimate goal at Celadon Pharmaceuticals goes beyond the immediate success of this trial. We aim to widen access to our innovative medicine through the National Health Service, ensuring that more patients can benefit from this cutting-edge treatment.
We are not just building medicine; we are building hope, comfort, and a better future for those plagued by chronic pain.